Agios Pharmaceuticals Stock Forecast

Buy candidate since Nov 14, 2025 Gain 3.79%

The Agios Pharmaceuticals, Inc. stock price gained 3.79% on the last trading day (Monday, 17th Nov 2025), rising from $43.73 to $45.39. It has now gained 9 days in a row. It is not often that stock manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 4.13% from a day low at $43.59 to a day high of $45.39. The price has risen in 9 of the last 10 days and is up by 9.66% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 138 more shares were traded than the day before. In total, 353 shares were bought and sold for approximately $16.02 thousand.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 18.25% during the next 3 months and, with a 90% probability hold a price between $47.91 and $55.46 at the end of this 3-month period.

0HB0.L Signals & Forecast

The Agios Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $42.96 and $41.91. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, November 04, 2025, and so far it has risen 13.47%. Further rise is indicated until a new top pivot has been found. Agios Pharmaceuticals, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Agios Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $41.00 and $36.74. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agios Pharmaceuticals, Inc. finds support just below today's level at $41.00. If this is broken, then the next support from accumulated volume will be at $36.74 and $35.55.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.80 between high and low, or 4.13%. For the last week, the stock has had daily average volatility of 3.09%.

Since the Agios Pharmaceuticals, Inc. has been rising for 9 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $43.65 (-3.82%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (0HB0.L) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Agios Pharmaceuticals, Inc. to open at $44.79, and during the day (based on 14 day Average True Range), to move between $44.72 and $46.06, which gives a possible trading interval of +/-$1.35 (+/-3.01%) up or down from last closing price. If Agios Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 3.01% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $41.00, some $4.39 (9.67%) from the current price of $45.39, our system finds the risk reward attractive.

Is Agios Pharmaceuticals, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agios Pharmaceuticals, Inc. stock to perform well in the short-term.

Current score: 2.006 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $44.79 ( 1.32%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk